Squarepoint’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.31M Buy
980,757
+540,320
+123% +$5.15M 0.02% 1177
2025
Q4
$5.35M Buy
440,437
+89,679
+26% +$1.09M 0.01% 1412
2025
Q3
$4.1M Buy
+350,758
New +$4.19M 0.01% 1584
2025
Q2
Sell
-45,054
Closed -$330K 4929
2025
Q1
$330K Buy
+45,054
New +$346K ﹤0.01% 3668
2024
Q4
Sell
-22,478
Closed -$196K 5441
2024
Q3
$196K Sell
22,478
-42,433
-65% -$350K ﹤0.01% 3694
2024
Q2
$444K Buy
64,911
+47,614
+275% +$294K ﹤0.01% 3167
2024
Q1
$157K Buy
17,297
+3,353
+24% +$23.8K ﹤0.01% 3691
2023
Q4
$62.2K Buy
+13,944
New +$41.2K ﹤0.01% 3827
2023
Q3
Sell
-13,689
Closed -$70.6K 4134
2023
Q2
$70.6K Buy
+13,689
New +$81.4K ﹤0.01% 3408
2022
Q4
Sell
-17,291
Closed -$72K 3512
2022
Q3
$72K Sell
17,291
-19,600
-53% -$98.7K ﹤0.01% 2832
2022
Q2
$148K Buy
+36,891
New +$139K ﹤0.01% 2554
2021
Q4
Sell
-19,913
Closed -$199K 3434
2021
Q3
$199K Sell
19,913
-14,768
-43% -$166K ﹤0.01% 2491
2021
Q2
$492K Buy
34,681
+14,655
+73% +$223K ﹤0.01% 2136
2021
Q1
$329K Buy
20,026
+9,711
+94% +$187K ﹤0.01% 2330
2020
Q4
$214K Sell
10,315
-106,531
-91% -$1.58M ﹤0.01% 2462
2020
Q3
$889K Sell
116,846
-32,411
-22% -$269K 0.01% 1059
2020
Q2
$1.24M Buy
149,257
+123,833
+487% +$821K 0.02% 832
2020
Q1
$126K Buy
+25,424
New +$126K ﹤0.01% 1595
2019
Q4
Sell
-14,348
Closed -$44K 2715
2019
Q3
$44K Buy
+14,348
New +$64.1K ﹤0.01% 2253
2018
Q1
Sell
-22,243
Closed -$99K 2007
2017
Q4
$99K Buy
+22,243
New +$114K ﹤0.01% 1961
2017
Q3
Sell
-15,703
Closed -$146K 1803
2017
Q2
$146K Buy
+15,703
New +$152K ﹤0.01% 1364
2017
Q1
Sell
-60,985
Closed -$510K 1807
2016
Q4
$510K Buy
+60,985
New +$473K 0.02% 816

Other funds holding OCUL